Literature DB >> 1792314

Should inhomogeneity corrections be applied during treatment planning of tangential breast irradiation?

B J Mijnheer1, S Heukelom, J H Lanson, L J van Battum, N A van Bree, G van Tienhoven.   

Abstract

Due to the inclusion of lung tissue in the treatment volume, some parts of the breast will get a higher dose during tangential breast irradiation because of the lower lung density. Data on the accuracy of dose calculation algorithms, investigated by phantom measurements, determinations of the geometry and density of the actual lung in the patient and the results of in vivo dose measurements, are presented. From this information it can be concluded that a lung correction varying between about 3% and 7% is needed but its magnitude is slightly overpredicted in a number of commercial treatment planning systems. Because this increase in dose is already in a high dose region, it is recommended that inhomogeneity corrections should be applied during tangential breast irradiation.

Entities:  

Mesh:

Year:  1991        PMID: 1792314     DOI: 10.1016/0167-8140(91)90156-b

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  4 in total

1.  Quality assurance of the EORTC Trial 22881/10882: boost versus no boost in breast conserving therapy. An overview.

Authors:  G van Tienhoven; B J Mijnheer; H Bartelink; D G González
Journal:  Strahlenther Onkol       Date:  1997-04       Impact factor: 3.621

Review 2.  Computed tomography imaging parameters for inhomogeneity correction in radiation treatment planning.

Authors:  Indra J Das; Chee-Wai Cheng; Minsong Cao; Peter A S Johnstone
Journal:  J Med Phys       Date:  2016 Jan-Mar

3.  Breast dose heterogeneity in CT-based radiotherapy treatment planning.

Authors:  R Prabhakar; G K Rath; P K Julka; T Ganesh; R C Joshi; N Manoharan
Journal:  J Med Phys       Date:  2008-04

4.  Anthropomorphic breast phantoms for quality assurance and dose verification.

Authors:  José A Bencomo; Connel Chu; Victor M Tello; Sang Hyun Cho; Geoffrey S Ibbott
Journal:  J Appl Clin Med Phys       Date:  2004-01-01       Impact factor: 2.102

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.